In the rapidly developing international medical devices market, MHW PR is helping to successfully take innovative new technology out of the laboratory and into the marketplace.
OJ Bio - a joint venture between Orla Protein Technologies Ltd and Japanese Radio Company - has developed next generation medical diagnostics that combine biotechnology processes with electronics manufacturing.
The result is a hand held device that provides fast and reliable diagnosis of diseases such as HIV, flu viruses and gum disease.
This means that patients can be diagnosed at the point of care - tests do not need to be sent away for analysis - which has tremendous advantages, not only for patients visiting their GP or health professional, but more broadly in dealing with health problems in more remote areas of developing countries.
MHW has worked with OJ Bio to help spread news of the new technology as part of a targeted marketing programme among medical and life science audiences around the world.
As a result, leading biomedical technology, clinical services, pharmaceutical and other specialist healthcare publications and online news platforms have all covered the new development, leading to growing commercial interest of the capability of the breakthrough.
TOOLKIT OF SERVICES